Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

AMEV

Applied Molecular Evolution (AMEV)

Applied Molecular Evolution, (MM)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:AMEV

1

Data	Hora	Fonte	Título	Código	Companhia
11/02/2004	17:24	PR Newswire (US)	AME Stockholders Approve Acquisition By Lilly	NASDAQ:AMEV	Applied Molecular Evolution, (MM)
02/01/2004	13:59	PR Newswire (US)	AME Sets January 5, 2004 as Record Date for Stockholder Meeting to Vote on Proposed Merger	NASDAQ:AMEV	Applied Molecular Evolution, (MM)
18/11/2003	12:00	PR Newswire (US)	Applied Molecular Evolution Files Investigational New Drug Application for AME-527, Next-Generation Remicade(R), in Rheumatoid A	NASDAQ:AMEV	Applied Molecular Evolution, (MM)
06/11/2003	14:14	PR Newswire (US)	Applied Molecular Evolution to Present at CIBC World Markets Healthcare Conference November 10	NASDAQ:AMEV	Applied Molecular Evolution, (MM)
04/11/2003	19:15	PR Newswire (US)	Applied Molecular Evolution, Inc. Reports Financial Results for Third Quarter 2003	NASDAQ:AMEV	Applied Molecular Evolution, (MM)